Trials / Completed
CompletedNCT02947815
Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm
A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase II/III Clinical Trial to Compare the Safety and Efficacy of NABOTA Versus BOTOX in Treatment of Essential Blepharospasm
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 234 (estimated)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the Efficacy and Safety of NABOTA in treatment of essential blepharospasm
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clostridium Botulinum Toxin Type A | |
| DRUG | Clostridium Botulinum Toxin Type A |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2018-01-01
- Completion
- 2018-01-01
- First posted
- 2016-10-28
- Last updated
- 2019-06-26
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02947815. Inclusion in this directory is not an endorsement.